Site Editors

Pan-TRK Immunodetection of NTRK Fusions in Atypical Melanocytic Tumors

Gastrointestinal Malignancies: Biomarker Analysis Via Immunohistochemistry

Comparing Next-Generation Sequencing Assays: Which Is Best for NTRK Fusion Detection?

Morphologic and Molecular Characterization of NTRK Fusion Uterine Sarcoma

EML4-NTRK Gene Fusion and ALK Inhibitor Resistance: Case Study in Advanced Lung Cancer

Cervical Small Cell Neuroendocrine Cancer: PD-L1 Expression and NTRK Gene Fusion

Understanding NTRK Fusions and Their Role in Tumorigenesis

Defining Molecular Characteristics of First- and Second-Generation TRK Inhibitors

Study Update of Larotrectinib in Adults With TRK Fusion–Positive Cancer

How Does Larotrectinib Measure Up Against Entrectinib in Treatment of Tumors With NTRK Fusion?

Efficacy of Non-TRK Inhibitor Therapy in Patients With and Without NTRK Fusion–Positive Tumors

Larotrectinib for NTRK Fusion Tumors: Can a Patient’s Disease Course Before Therapy Affect Outcomes?

How Common Are NTRK1/2/3 Fusions in Colorectal Cancer?

How Familiar Are Health-Care Professionals With NTRK Fusion Testing in Patients With Solid Tumors?

ESMO 2021: Skeletal Fractures in Patients Treated With Larotrectinib for TRK Fusion–Positive Cancer

FDA Grants Breakthrough Therapy Designation to Repotrectinib for Solid Tumors With NTRK Gene Fusions

Case Study of NTRK1-Rearranged Cervical Sarcoma: Focus on Neoadjuvant TRK Inhibition and Surgery

Understanding NTRK Fusions in Premalignant Colorectal Lesions

ESMO 2021: Does Prior Therapy or Performance Status Affect Larotrectinib Response in TRK Fusion–Positive Cancer?

Molecular Characterization of Pediatric Versus Adult Papillary Thyroid Cancers

ESMO 2021: NTRK Fusion and KRAS Variation in Colorectal and Lung Cancers

ESMO 2021: Updated Analysis of Entrectinib in Advanced NTRK Fusion–Positive Solid Tumors

ESMO 2021: Dutch Study Focuses on NTRK Fusions as Potential Prognostic Biomarker

Rare Case of Recurrent Secretory Carcinoma of the Breast With NTRK3 Gene Fusion

Head and Neck Cancer in Chinese Patients: Focus on NTRK Aberrations

Novel Gene Fusion Partners in Sarcomas: Focus on NTRK for Targeted Therapy

NTRK Gene Fusion Analysis: Real-World Database of Patients With Cancer

Creative Treatment Approach to Advanced Salivary Gland Cancer With ETV6-NTRK3 Fusion: Case Study

Reassessing NTRK Testing in Patients With Bone Tumors

NTRK Gene Fusion Testing and Treatment Modifications: Survey of Medical Oncologists

Closer Look at NTRK Gene Fusions in Chinese Patients With Colorectal Cancer

Larotrectinib in TRK Fusion–Positive Cancers: Long-Term Follow-up

NTRK Gene Fusion in Middle Eastern Patients With Papillary Thyroid Cancer

Patterns of PD-L1 Expression in NSCLC Harboring Driver Oncogene Mutations Including NTRK Fusions

Positivity and Translocations of FGFR2 and NTRK1 in Intrahepatic Cholangiocarcinoma

UK Genomes Project: Are NTRK Gene Fusions Actionable Biomarkers?

Efficacy of Screening Methods for NTRK Gene Fusions in Solid Tumors